Elisabeth M. Jongbloed
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.
Journal: Nature medicine
Published: February 24, 2025
A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.
Journal: Breast cancer research : BCR
Published: November 22, 2024
Pseudo acute kidney injury in patients receiving CDK4/6 inhibitors.
Journal: British journal of cancer
Published: August 21, 2024
Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels.
Journal: Scientific reports
Published: March 27, 2023
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients' Needs?
Journal: Breast cancer (Dove Medical Press)
Published: September 19, 2022
Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicity.
Journal: The EMBO journal
Published: June 10, 2021
A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients.
Journal: Cancers
Published: February 27, 2021
HLH caused by an HSV-2 infection: a case report and review of the literature.
Journal: The Netherlands journal of medicine
Published: October 23, 2020
Association Between Self-Reported Spinal Morning Stiffness and Radiographic Evidence of Lumbar Disk Degeneration in Participants of the Cohort Hip and Cohort Knee (CHECK) Study.
Journal: Physical therapy
Published: April 24, 2019
The association between pro-inflammatory biomarkers and nonspecific low back pain: a systematic review.
Journal: The spine journal : official journal of the North American Spine Society
Published: January 17, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026